CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Grant or award Chief Financial Officer acquired 158,108 shares (grant or award)
- 4 Grant or award Director acquired 5,659 shares (grant or award)
- 4 Grant or award Director acquired 50,378 shares (grant or award)
- 4 Grant or award JOHNSON KENNETH ERLAND acquired 89,583 shares (grant or award)
- 4 Grant or award Hecht Beth acquired 206,366 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 9 of 9 · 178 filings